News
-
-
PRESS RELEASE
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
Bausch Health Canada expands UCERIS availability in Canadian public drug plans for ulcerative colitis treatment. UCERIS foam offers better tolerability and application compared to enema -
-
PRESS RELEASE
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
Bausch Health & Salix Pharmaceuticals to present Phase 2 trial data on Amiselimod for ulcerative colitis treatment at DDW 2024. Positive results announced in 2023 -
-
-
-
PRESS RELEASE
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Bausch Health and Salix Pharmaceuticals provide updates on litigation with Norwich Pharmaceuticals and potential generic version of XIFAXAN. Bausch Health to enforce intellectual property rights. Details on FDA approval process and patent infringement lawsuit -
-
PRESS RELEASE
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Bausch Health and Salix Pharmaceuticals announce Bellamy Young as Xifaxan brand ambassador to raise awareness on OHE recurrence risk reduction. Campaign aims to educate about complications of cirrhosis
-
Revolutionizing Fire Camps: NUE's Sustainable Power Solutions Shine at USDA Technology & Development Center
-
Save A Train Continues to Innovate with Rail Enrichment
-
Cameron Ashley Building Products Opens Third Location in the Badger State
-
Event Tickets Center is Named Official Secondary Ticketing Reseller Partner for Most Valuable Promotions and the Historic Jake Paul vs. Mike Tyson Fight
-
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect
-
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
-
secunet Security Networks AG successfully holds Annual General Meeting – Broad approval for all proposed resolutions
-
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
AngloGold Ashanti US$9.0m (A$13.5m) Gold Farm-in Agreement
-
2024 Annual General Meeting: approval of all resolutions submitted to the Meeting
-
PR – ICADE – Success of the cash tender offer for a total amount of €350 million
-
AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
-
Availability of preparatory documents for the annual general meeting of June 13, 2024
-
Safran’s 2024 Annual General Meeting